The Choice of Enzyme for Human Pancreas Digestion is a Critical Factor for Increasing the Success of Islet Isolation.

作者: Meirigeng Qi , Luis Valiente , Brian McFadden , Keiko Omori , Shiela Bilbao

DOI: 10.1097/TXD.0000000000000522

关键词:

摘要: Successful human islet isolation is essential for clinical and research applications,1-4 greatly influenced by selecting appropriate enzyme(s) pancreas digestion.5-10 Hence, developing using consistently high-quality enzymes a key element isolations. Advancements in obtaining non-good manufacturing practice liberase HI indeed made major progress to achieve successful isolation11,12 allowed an increase the number of patients receiving transplants.13 However, 2007, use isolations was ceased due safety concerns possible prion contamination from bovine tissue-derived raw materials.14 Liberase mixture collagenase neutral protease (NP) not highly purified hence, lot-to-lot variability concern failure long term storage sporadic.9,12,15 Therefore, there great demand GMP-grade, pure, low endotoxin digestion enzyme replace among specialists commercial manufacturers obtain high quality islets.6,16-18 Consequently, NB1 supplemented with NP adopted many centers globally as alternative isolation.6,19,20 Indeed, several have been transplanted islets isolated this enzyme, suggesting that may be promising product replacing HI. limitation its efficacy isolate younger donors ultimate outcome different donor populations. Furthermore, it has reported contains degraded collagenase; therefore, higher doses are required isolations.8,21 Collagenase, NP, clostripain produced Clostridium histolyticum,15 whereas thermolysin Bacillus thermoproteolyticus rokko.12 Collagenase (class I II isoforms) either Thermolysin or currently used digestion. combination CIzyme HA (containing nondegradable class [60%] [40%]) found effective isolating transplantation, but GMP products.21 mammalian tissue-free collagenase/thermolysin (MTF C/T) shown transplantation compared NB1/NP.6,22 All types aforementioned purposes. advantage particular specific supplier over another debatable often subjectively determined team's experiences.21,23 It overall NB1/NP comparable HI.5,19 In retrospective analysis, 221 pancreata 3 commercially available enzymes, HI, NB1/NP, MTF C/T were compared.

参考文章(57)
Masaaki Miyamoto, Yoshihiko Morimoto, Yuka Nozawa, A. N. Balamurugan, Baoyou Xu, Kazutomo Inoue, Establishment of fluorescein diacetate and ethidium bromide (FDAEB) assay for quality assessment of isolated islets. Cell Transplantation. ,vol. 9, pp. 681- 686 ,(2000) , 10.1177/096368970000900514
AN Balamurugan, B Naziruddin, A Lockridge, M Tiwari, G Loganathan, M Takita, S Matsumoto, K Papas, M Trieger, H Rainis, T Kin, TW Kay, S Wease, S Messinger, C Ricordi, R Alejandro, J Markmann, J Kerr-Conti, MR Rickels, C Liu, X Zhang, P Witkowski, A Posselt, P Maffi, A Secchi, T Berney, PJ O’Connell, BJ Hering, FB Barton, Islet Product Characteristics and Factors Related to Successful Human Islet Transplantation From the Collaborative Islet Transplant Registry (CITR) 1999–2010 American Journal of Transplantation. ,vol. 14, pp. 2595- 2606 ,(2014) , 10.1111/AJT.12872
I. R. Sweet, M. Gilbert, S. Scott, I. Todorov, R. Jensen, I. Nair, I. Al-Abdullah, J. Rawson, F. Kandeel, K. Ferreri, Glucose-Stimulated Increment in Oxygen Consumption Rate as a Standardized Test of Human Islet Quality American Journal of Transplantation. ,vol. 0, pp. 071117175452004- ??? ,(2007) , 10.1111/J.1600-6143.2007.02041.X
Robert C. McCarthy, Andrew G. Breite, Michael L. Green, Francis E. Dwulet, Tissue Dissociation Enzymes for Isolating Human Islets for Transplantation: Factors to Consider in Setting Enzyme Acceptance Criteria Transplantation. ,vol. 91, pp. 137- 145 ,(2011) , 10.1097/TP.0B013E3181FFFF7D
Darin J. Weber, FDA regulation of allogeneic islets as a biological product Cell Biochemistry and Biophysics. ,vol. 40, pp. 19- 22 ,(2004) , 10.1385/CBB:40:3:19
A. Gangemi, P. Salehi, B. Hatipoglu, J. Martellotto, B. Barbaro, J. B. Kuechle, M. Qi, Y. Wang, P. Pallan, C. Owens, J. Bui, D. West, B. Kaplan, E. Benedetti, J. Oberholzer, Islet Transplantation for Brittle Type 1 Diabetes: The UIC Protocol American Journal of Transplantation. ,vol. 8, pp. 1250- 1261 ,(2008) , 10.1111/J.1600-6143.2008.02234.X
Federico Bertuzzi, Silvia Cainarca, Simona Marzorati, Angela Bachi, Barbara Antonioli, Rita Nano, Roberto Verzaro, Camillo Ricordi, Collagenase isoforms for pancreas digestion. Cell Transplantation. ,vol. 18, pp. 203- 206 ,(2009) , 10.3727/096368909788341270
S. Merani, C. Toso, J. Emamaullee, A. M. J. Shapiro, Optimal implantation site for pancreatic islet transplantation British Journal of Surgery. ,vol. 95, pp. 1449- 1461 ,(2008) , 10.1002/BJS.6391
Marcio Fronza, Guilherme F Caetano, Marcel N Leite, Claudia S Bitencourt, Francisco WG Paula-Silva, Thiago AM Andrade, Marco AC Frade, Irmgard Merfort, Lúcia H Faccioli, None, Hyaluronidase Modulates Inflammatory Response and Accelerates the Cutaneous Wound Healing PLoS ONE. ,vol. 9, pp. e112297- ,(2014) , 10.1371/JOURNAL.PONE.0112297
Tatsuya Kin, Doug O’Gorman, Xiaojun Zhai, Rena Pawlick, Sharleen Imes, Peter Senior, A M. James Shapiro, Nonsimultaneous administration of pancreas dissociation enzymes during islet isolation. Transplantation. ,vol. 87, pp. 1700- 1705 ,(2009) , 10.1097/TP.0B013E3181A60240